RecruitingNot ApplicableNCT05862649

Evaluation of Correlation Between Oculometric Measures and Clinical Assessment in Parkinson's Disease

A Multicenter Longitudinal Study to Evaluate the Correlation Between Oculometric Measures and Clinical Assessment in Patients With Idiopathic Parkinson's Disease (PALOMA Trial)

Sponsor

NeuraLight

Enrollment

300 participants

Start Date

Aug 21, 2023

Study Type

INTERVENTIONAL

Conditions

Parkinson Disease

Summary

This is a multicenter longitudinal study in about 300 patients with Idiopathic Parkinson's disease, who will be evaluated in several clinical centers with a clinical assessment and an oculometric examination during a time period with specific intervals. This study aims to evaluate the correlation between oculometric measures and clinical assessment over time, as well as the potential to detect early change in clinical status using an oculometric assessment.

Eligibility

Min Age: 40 YearsMax Age: 85 Years

Plain Language Summary

Simplified for easier understanding

This study explores whether eye movement tests (oculometrics) can serve as a simple, objective tool to measure disease severity and track changes in people with early-stage Parkinson's disease. **You may be eligible if...** - You have been diagnosed with idiopathic Parkinson's disease in the early stages (Hoehn & Yahr 1–2) - You are between 40 and 85 years old and were diagnosed no more than 5 years ago - You have normal vision or use corrective lenses - If you are on Parkinson's medication, your dose has been stable for at least 3 months **You may NOT be eligible if...** - You cannot sit still for 40 minutes - You or a close family member has a history of epilepsy - You have other neurological conditions - You have a current drug or alcohol problem - You are pregnant or may be pregnant Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.